Skip to main content

SGD Pharma held its European Suppliers Day bringing together about 100 stakeholders of the glass and sustainability ecosystem on June 18th

SGD Pharma held its European Suppliers Day bringing together about 100 stakeholders of the glass and sustainability ecosystem on June 18th

SGD Pharma’s Suppliers Day held on June 18th near Paris was a resounding success bringing together about 100 stakeholders of the glass and sustainability ecosystem: major suppliers of the glass industry (glass technologies, energies, raw materials, logistics, packaging,..), non-governmental organizations (United Nations, Reforest'Action) and key stakeholders of SGD Pharma’s global CSR strategy.

SGD Pharma releases its latest sustainability report underscoring its global commitment to the highest environmental, social and governance standards

SGD Pharma, global leader in glass pharmaceutical packaging, has published its latest 2023 Corporate Social Responsibility (CSR) Report illustrating the sustainable practices deeply embedded in its business ethos

 

SGD Pharma Zhanjiang plant celebrated the renovation of its furnace with a lighting ceremony

 On April 18th, SGD Pharma Zhanjiang plant celebrated the renovation of its furnace with a lighting ceremony.

According to the century-old French glass maker tradition, the new furnace was lighted by its godmother.

SGD Pharma announces the appointment of Philippe Pourquery as Group Financial Officer and member of the Executive Committee

Philippe Pourquery will join SGD Pharma, global leader in glass pharmaceutical packaging, from May 6, 2024 as Group Financial Officer and member of the Executive Committee, in replacement of Jérôme Brassens. Philippe will be responsible for Finance and IT across the Group.

SGD Pharma successfully trials hydrogen burners at its Saint-Quentin-Lamotte (SQLM) plant to accelerate its ambitious decarbonization roadmap

At the end of January, SGD Pharma, a global leader in glass primary packaging for the pharmaceutical industry, started a two-week trial using 100% hydrogen burners for industrial-scale glass production. The trial, conducted at SGD Pharma’s state-of-the-art Saint-Quentin-Lamotte (SQLM) manufacturing plant in France, was a resounding success and will inform SGD Pharma’s decarbonization roadmap which aims to reduce CO2 emissions from 2020 by 35% in 2030 and by 65% in 2040.

Subscribe to